Pular para o conteúdo
Menu
Mix Vale

Chlorthalidone 25 mg recall expands to 13,567 bottles as FDA warns of dissolution testing failure

Luís Henrique Costa
Por 3 min de leitura
Compartilhe
Remédios, medciamentos e Pílulas
Foto: Remédios, medciamentos e Pílulas - Foto: MOLEQL/shutterstock.com

Drugmaker Inventia Healthcare initiated a nationwide voluntary recall of 13,567 bottles of the blood pressure treatment chlorthalidone after samples failed quality specifications. Laboratory evaluations revealed that the 25-milligram tablets do not dissolve within established time standards, a defect that can prevent the body from absorbing the active ingredient and undermine hypertension control.

Publicidade

The corrective action targets 100-count bottles circulated across the United States supply chain. Regulators identified the issue during dissolution profiling, which demonstrated that the pills disintegrate too slowly to guarantee appropriate therapeutic delivery. Medical specialists advise patients using the medication to check their prescription labels while continuing their regimen under clinical supervision.

Medicamento
Photo: Medicamento – Foto: IMAG3S/istock

The United States Food and Drug Administration assigned a Class II designation to the market withdrawal on September 17, 2026. Under agency definitions, this classification applies to situations where exposure to a noncompliant product may trigger temporary or medically reversible health issues, while the risk of severe adverse outcomes remains remote.

Publicidade

Affected lot details and regulatory registry numbers

  • Product: Chlorthalidone tablets USP 25 mg in 100-count bottles
  • Affected lot number: RISA24002
  • National Drug Code: 64980-599-01
  • Expiration date: April 2027
  • FDA enforcement database entry: D-0852-2026

Nationwide distribution and previous manufacturing actions

Manufactured in India by Inventia Healthcare Limited, the diuretic is marketed and supplied across the American market by Rising Pharma Holdings Inc., based in East Brunswick, New Jersey. The pharmaceutical firm formally initiated the voluntary recall on September 3, 2026, following internal and regulatory testing evaluations. This latest withdrawal pushes the total volume of chlorthalidone recalled by the company past 25,000 bottles in 2026, adding to an earlier batch of 11,460 bottles pulled in June due to similar disintegration problems.

Read also: FDA discute uso de testosterona em mulheres na menopausa em meio a desafios de acesso e dosagem

Clinical guidance regarding hypertension treatment regimens

Cardiologists and public health agencies warn that individuals taking tablets from the flagged lot must avoid stopping their prescriptions abruptly. Chlorthalidone is widely prescribed to manage chronic hypertension and treat fluid buildup related to cardiac, liver, and kidney conditions, meaning an unmonitored cessation could trigger dangerous blood pressure spikes or cardiovascular events. Patients who verify that their medication belongs to the recalled batch should consult their prescribing physician or dispensing pharmacist to arrange an effective alternative therapy.

Keep reading: FDA classifies recall of six hand soaps across 15 states

Inventia Healthcare did not issue public statements or reply to media requests for comment prior to the release of the agency enforcement records. Retailers and distribution facilities holding the affected inventory have been instructed to halt sales and process returns through standard pharmaceutical recovery channels.

Publicidade

Luís Henrique Costa é jornalista formado pela FMU, editor-chefe e fundador do Mix Vale, portal de notícias em atividade desde 2011. Responde pela direção editorial do veículo, que cobre Brasil e mundo em economia, benefícios sociais, esportes, tecnologia, ciência e entretenimento. Atua na área há mais de 15 anos e lidera uma equipe de cerca de 15 colaboradores.

Notícias relacionadas

Mais lidas

  1. Ciência

    Meteoro no Nordeste: bólido cruza o céu de cinco estados às 21h34 e mobiliza buscas por fragmentos na Paraíba

  2. Caixa Econômica Federal

    Pé-de-Meia paga parcela de R$ 1.000,00 a aprovados no ensino médio de 2026 entre fevereiro e março de 2027

  3. Política

    Com obstrução parcial no intestino, Jair Bolsonaro é internado no hospital DF Star em Brasília

  4. INSS

    Recuperação da senha Gov.br pelo celular exige reconhecimento facial ou código por SMS para o Meu INSS

  5. EUA

    Terremoto em Los Angeles atinge magnitude 4,2 e causa tremores leves em Commerce na madrugada

  6. Matéria Publicitária

    MineMV é o novo jogo grátis de construir com blocos; veja como jogar e liberado para todas as idades

  7. Política

    Regulamentação da escala 5×2 pelo governo encarece cálculo da hora extra a partir de 16 de dezembro

  8. Santa Catarina

    Acidente de trânsito na SC-108 envolve carro e moto e deixa motociclista morto em São Ludgero

  9. Mundo

    Jornalista italiano Corrado Augias morre aos 91 anos; presidente da Itália lamenta a perda

  10. Loterias

    Rendimento de R$ 40 milhões da Mega-Sena 3088 chega a R$ 337 mil por mês no Tesouro Direto